Management, therapy and outcome of treatment in women with pelvic endometriosis.
Sixty-four cases of endometriosis treated between 1980 and 1985 were reclassified according to the R-A.F.S. Twenty-eight of the patients (43.7%) were followed for 24-39 months: in this group we evaluated the efficiency of medical treatment (Danazol), combined medical and conservative surgical or definitive surgical treatment on the basis of the persistence, complete or partial regression of the symptoms. In this group of patients the symptoms regressed completely in 39.28% of the cases; in 28.57% there was a partial regression and persistence or recurrence of the symptoms were reported in 32.14%. These results suggest that the classification system is a key to interpreting treatment.
Parodo
G
G
Department of Obstetrics and Gynecology, University Medical School, Cagliari, Italy.
Marcello
C
C
Medda
F
F
Puligheddu
P
P
Rassu
G
G
Fiore
R
R
Lecca
U
U
D000293:Adolescent; D000328:Adult; D003131:Combined Modality Therapy; D003613:Danazol / Q000627:therapeutic use; D004715:Endometriosis / Q000473:pathology / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D005833:Genital Neoplasms, Female / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D009367:Neoplasm Staging; D010052:Ovariectomy
D003613:Danazol